521 related articles for article (PubMed ID: 29727835)
1. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin.
Lim LM; Tran TT; Long Wong JJ; Wang D; Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2018 Jul; 167():483-491. PubMed ID: 29727835
[TBL] [Abstract][Full Text] [Related]
2. Effects of chitosan molecular weight on the physical and dissolution characteristics of amorphous curcumin-chitosan nanoparticle complex.
Yu H; Nguyen MH; Hadinoto K
Drug Dev Ind Pharm; 2018 Jan; 44(1):82-88. PubMed ID: 28849675
[TBL] [Abstract][Full Text] [Related]
3. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
Nguyen MH; Yu H; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
[TBL] [Abstract][Full Text] [Related]
4. A simple strategy to enhance the in vivo wound-healing activity of curcumin in the form of self-assembled nanoparticle complex of curcumin and oligochitosan.
Nguyen MH; Lee SE; Tran TT; Bui CB; Nguyen TH; Vu NB; Tran TT; Nguyen TH; Nguyen TT; Hadinoto K
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():54-64. PubMed ID: 30813056
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP.
Dong B; Lim LM; Hadinoto K
Eur J Pharm Sci; 2019 Oct; 138():105035. PubMed ID: 31386892
[TBL] [Abstract][Full Text] [Related]
6. A new bioavailability enhancement strategy of curcumin via self-assembly nano-complexation of curcumin and bovine serum albumin.
Yu H; Nguyen MH; Cheow WS; Hadinoto K
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():25-33. PubMed ID: 28415461
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the stability of amorphous drug-polyelectrolyte nanoparticle complex using a secondary small-molecule drug as the stabilizer: A case study of ibuprofen-stabilized curcumin-chitosan nanoplex.
Lim LM; Hadinoto K
Int J Pharm; 2020 Feb; 575():119007. PubMed ID: 31893545
[TBL] [Abstract][Full Text] [Related]
8. High-Payload Buccal Delivery System of Amorphous Curcumin-Chitosan Nanoparticle Complex in Hydroxypropyl Methylcellulose and Starch Films.
Lim LM; Hadinoto K
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502305
[TBL] [Abstract][Full Text] [Related]
9. Millifluidic synthesis of amorphous drug-polysaccharide nanoparticle complex with tunable size intended for supersaturating drug delivery applications.
Tran TT; Nguyen MH; Tan YZ; Chew JW; Khan SA; Hadinoto K
Eur J Pharm Biopharm; 2017 Mar; 112():196-203. PubMed ID: 27903456
[TBL] [Abstract][Full Text] [Related]
10. Lyophilization of Curcumin-Albumin Nanoplex with Sucrose as Cryoprotectant: Aqueous Reconstitution, Dissolution, Kinetic Solubility, and Physicochemical Stability.
Chua A; Tran TT; Pu S; Park JW; Hadinoto K
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233033
[TBL] [Abstract][Full Text] [Related]
11. A supersaturating delivery system of silibinin exhibiting high payload achieved by amorphous nano-complexation with chitosan.
Nguyen MH; Yu H; Dong B; Hadinoto K
Eur J Pharm Sci; 2016 Jun; 89():163-71. PubMed ID: 27140843
[TBL] [Abstract][Full Text] [Related]
12. A trade-off between solubility enhancement and physical stability upon simultaneous amorphization and nanonization of curcumin in comparison to amorphization alone.
Wong JJL; Yu H; Lim LM; Hadinoto K
Eur J Pharm Sci; 2018 Mar; 114():356-363. PubMed ID: 29309874
[TBL] [Abstract][Full Text] [Related]
13. Amorphous nanoparticle complex of perphenazine and dextran sulfate as a new solubility enhancement strategy of antipsychotic perphenazine.
Dong B; Hadinoto K
Drug Dev Ind Pharm; 2017 Jun; 43(6):996-1002. PubMed ID: 28121189
[TBL] [Abstract][Full Text] [Related]
14. Carboxymethyl cellulose is a superior polyanion to dextran sulfate in stabilizing and enhancing the solubility of amorphous drug-polyelectrolyte nanoparticle complex.
Dong B; Hadinoto K
Int J Biol Macromol; 2019 Oct; 139():500-508. PubMed ID: 31386874
[TBL] [Abstract][Full Text] [Related]
15. A Potential Quorum-Sensing Inhibitor for Bronchiectasis Therapy: Quercetin-Chitosan Nanoparticle Complex Exhibiting Superior Inhibition of Biofilm Formation and Swimming Motility of
Tran TT; Hadinoto K
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546487
[TBL] [Abstract][Full Text] [Related]
16. Crystalline Ethylene Oxide and Propylene Oxide Triblock Copolymer Solid Dispersion Enhance Solubility, Stability and Promoting Time- Controllable Release of Curcumin.
Alves TFR; das Neves Lopes FCC; Rebelo MA; Souza JF; da Silva Pontes K; Santos C; Severino P; Junior JMO; Komatsu D; Chaud MV
Recent Pat Drug Deliv Formul; 2018; 12(1):65-74. PubMed ID: 29345599
[TBL] [Abstract][Full Text] [Related]
17. Curcumin amorphous solid dispersions benefit from hydroxypropyl methylcellulose E50 to perform enhanced anti-inflammatory effects.
Zhang J; Shi X; Tao W
Int J Biol Macromol; 2023 Dec; 252():126507. PubMed ID: 37633564
[TBL] [Abstract][Full Text] [Related]
18. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
Wang F; Yang Y; Ju X; Udenigwe CC; He R
J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
20. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs.
Cheow WS; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():314-21. PubMed ID: 26325060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
